UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

[OP.6B.02] LONG-TERM EFFECTS OF ADRENALECTOMY OR SPIRONOLACTONE ON ARTERIAL STIFFNESS IN PRIMARY ALDOSTERONISM

Journal of hypertension, 2017-09, Vol.35 Suppl 2 - ESH 2017 Abstract Book (Supplement 2), p.e58-e58

2017

Volltextzugriff (PDF)

[OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY

Journal of hypertension, 2016-09, Vol.34 Suppl 2 - ESH 2016 Abstract Book (Supplement 2), p.e96-e97

2016

Volltextzugriff (PDF)

High incidence of cardiovascular complications in pheochromocytoma

Hormone and metabolic research, 2012-05, Vol.44 (5), p.379

2012

Volltextzugriff (PDF)

Changes in Energy Metabolism in Pheochromocytoma

The journal of clinical endocrinology and metabolism, 2013-04, Vol.98 (4), p.1651-1658

2013

Volltextzugriff (PDF)

Pheochromocytoma and markers of oxidative stress

Physiological research, 2013-01, Vol.62 (3), p.331-335

2013

Volltextzugriff (PDF)

Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension

Journal of human hypertension, 2016-01, Vol.30 (1), p.35-39

2016

Volltextzugriff (PDF)

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism

Journal of human hypertension, 2010-10, Vol.24 (10), p.625-630

2010

Volltextzugriff (PDF)

Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?

Journal of human hypertension, 2014-11, Vol.28 (11), p.684-688

2014

Volltextzugriff (PDF)

Have main types of primary aldosteronism different phenotype?

Physiological research, 2012-01, Vol.61 (4), p.431-436

2012

Volltextzugriff (PDF)

Inflammatory markers in primary aldosteronism

Physiological research, 2016-01, Vol.65 (2), p.229-237

2016

Volltextzugriff (PDF)

The effect of adrenalectomy on exercise response of the renin-angiotensin-aldosterone system and exercise tolerance in primary aldosteronism

Physiological research, 2018-01, Vol.67 (2), p.233-238

2018

Volltextzugriff (PDF)

Relationship between clinical, 24-hour, average day-time and night-time blood pressure and measures of arterial stiffness in essential hypertension

Physiological research, 2008-01, Vol.57 (2), p.303-306

2008

Volltextzugriff (PDF)

Lower physical fitness in patients with primary aldosteronism is linked to the severity of hypertension and kalemia

Physiological research, 2017-01, Vol.66 (1), p.41-48

2017

Volltextzugriff (PDF)

Peripheral arterial stiffness in primary aldosteronism

Physiological research, 2012-01, Vol.61 (5), p.461-468

2012

Volltextzugriff (PDF)

[PP.27.12] DIFFERENCES BETWEEN HYPERMETABOLIC AND NORMOMETABOLIC PHEOCHROMOCYTOMA

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e314

2017

Volltextzugriff (PDF)

The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue

Physiological research, 2009-01, Vol.58 (3), p.319-325

2009

Volltextzugriff (PDF)

Vascular Disturbances in Primary Aldosteronism: Clinical Evidence

Kidney & blood pressure research, 2012-01, Vol.35 (6), p.529-533

2012

Volltextzugriff (PDF)

THE EFFECT OF PHEOCHROMOCYTOMA TREATMENT ON SUBCLINICAL INFLAMMATION AND ENDOCRINE FUNCTION OF ADIPOSE TISSUE

European journal of internal medicine, 2008, Vol.19, p.S46-S46

2008

Volltextzugriff (PDF)

PP.35.27: REASONS FOR SWITCHING ANTIHYPERTENSIVE MEDICATION IN GENERAL PRACTICE A CROSS-SECTIONAL CZECH NATION-WIDE SURVEY

Journal of hypertension, 2015-06, Vol.33 (Supplement 1), p.e457

2015

Volltextzugriff (PDF)

PP.09.08: EARLY POSTOPERATIVE TESTING IN PHEOCHROMOCYTOMA. IS IT FEASIBLE?

Journal of hypertension, 2015-06, Vol.33 (Supplement 1), p.e210-e211

2015

Volltextzugriff (PDF)

PREDICTION OF LONG-TERM RENAL DENERVATION EFFICACY

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e48

2018

Volltextzugriff (PDF)

Adrenalectomy Improves Arterial Stiffness in Primary Aldosteronism

American journal of hypertension, 2008-10, Vol.21 (10), p.1086-1092

2008

Volltextzugriff (PDF)

Biochemical Testing After Pheochromocytoma Removal: How Early?

Hormone and metabolic research, 2015-08, Vol.47 (9), p.633

2015

Volltextzugriff (PDF)

P756Renal denervation in comparison to intensified pharmacotherapy in true resistant hypertension. Two-year outcomes of randomised PRAGUE-15 study

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Increased Arterial Wall Stiffness in Primary Aldosteronism in Comparison With Essential Hypertension

American journal of hypertension, 2006-09, Vol.19 (9), p.909-914

2006

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(133)
Tagungsberichte
(3)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

[OP.6B.02] LONG-TERM EFFECTS OF ADRENALECTOMY OR SPIRONOLACTONE ON ARTERIAL STIFFNESS IN PRIMARY ALDOSTERONISM

[OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY

High incidence of cardiovascular complications in pheochromocytoma

Changes in Energy Metabolism in Pheochromocytoma

Pheochromocytoma and markers of oxidative stress

Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism

Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?

Have main types of primary aldosteronism different phenotype?

Inflammatory markers in primary aldosteronism

The effect of adrenalectomy on exercise response of the renin-angiotensin-aldosterone system and exercise tolerance in primary aldosteronism

Relationship between clinical, 24-hour, average day-time and night-time blood pressure and measures of arterial stiffness in essential hypertension

Lower physical fitness in patients with primary aldosteronism is linked to the severity of hypertension and kalemia

Peripheral arterial stiffness in primary aldosteronism

[PP.27.12] DIFFERENCES BETWEEN HYPERMETABOLIC AND NORMOMETABOLIC PHEOCHROMOCYTOMA

The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue

Vascular Disturbances in Primary Aldosteronism: Clinical Evidence

THE EFFECT OF PHEOCHROMOCYTOMA TREATMENT ON SUBCLINICAL INFLAMMATION AND ENDOCRINE FUNCTION OF ADIPOSE TISSUE

PP.35.27: REASONS FOR SWITCHING ANTIHYPERTENSIVE MEDICATION IN GENERAL PRACTICE A CROSS-SECTIONAL CZECH NATION-WIDE SURVEY

PP.09.08: EARLY POSTOPERATIVE TESTING IN PHEOCHROMOCYTOMA. IS IT FEASIBLE?

PREDICTION OF LONG-TERM RENAL DENERVATION EFFICACY

Adrenalectomy Improves Arterial Stiffness in Primary Aldosteronism

Biochemical Testing After Pheochromocytoma Removal: How Early?

P756Renal denervation in comparison to intensified pharmacotherapy in true resistant hypertension. Two-year outcomes of randomised PRAGUE-15 study

Increased Arterial Wall Stiffness in Primary Aldosteronism in Comparison With Essential Hypertension

Suchergebnisse filtern